NACDS urging flexible health IT approach as HHS works to adjust patient records law
WHAT IT MEANS AND WHY IT’S IMPORTANT Shifting the nation’s sprawling and disconnected healthcare system to an integrated platform, based at last on health information technology and electronic health records, is a worthy and overdue undertaking. But striking the right balance between opening the spigot of patient information to streamline care and improve decision-making by health professionals, while protecting patient privacy, is a challenge that both health professionals and government policy-makers have been grappling with since the advent of computers in physicians’ offices and pharmacies.
(THE NEWS: White House continues health IT drive as CMS offers matching funds to states. For the full story, click here)
There’s no disputing the value health IT and EHRs can bring to this nation’s fractured and sometimes irrational system of health care. A fully integrated network that exchanges patient records among health professionals would revolutionize the whole system, knocking down silos and linking up the doctors, labs, pharmacies, nursing groups and health plans that all play a key role in a patient’s health and wellbeing, and getting them finally to talk to one another. The result could be a dramatic reduction in costs for needless and redundant tests, double-filled prescriptions, drug interactions and non-adherence. It would mean a smarter and far more cost-effective network for improving patient outcomes and rationalizing the decisions made by health stakeholders in patients’ care regimens.
Understandably, the federal health officials charged with driving the health IT revolution are moving cautiously, even as they continue to open the stimulus funding spigot for adoption of EHRs to more states.
Their goal: to avoid compromising the privacy of patients’ health records in the conversion to electronic recordkeeping and transmission of patient data. But privacy concerns, argue pharmacy advocates, needn’t block the necessary flow of protected patient data that must occur if a more integrated and rational health care system is to become more than just an elusive and always out-of-reach pipe dream.
On Monday, the National Association of Chain Drug Stores took another stab at the issue, with a written plea to Secretary of Health and Human Services Kathleen Sebelius. Essentially, NACDS is asking the White House to maintain a flexible and workable approach as it uses its stimulus funds and regulatory powers to usher in the electronic health revolution.
That means, NACDS told Sebelius, that the government shouldn’t impose on pharmacies and physicians a requirement that they obtain prior authorization from patients for the use and transmission of protected health records.
NACDS is on solid ground here. Two major considerations support their plea to HHS: one, the privacy of patient data is already amply protected by the privacy statutes embodied in the Health Information Portability and Accountability Act of 1996, or HIPAA. Two, the imposition of disclosure requirements and “opt-in, opt-out” prior-authorization rules on every patient exchange with a doctor or pharmacist could create enough confusion and bottlenecks to ground the nation’s critically important transformation to health IT to a halt.
MDA offers vouchers for free flu shots at Walgreens
SALT LAKE CITY Walgreens is teaming up with the Muscular Dystrophy Association to administer flu shots to those who need them most, according to published reports.
The MDA is handing out vouchers for free flu shots at Walgreens to those affected by muscular dystrophy and related diseases, according to ABC4News in Salt Lake City.
Voucher requests can be submitted here.
CBO: Generics saved $33 billion for Medicare Part D in 2007
WASHINGTON Generic drugs saved Medicare Part D beneficiaries and the program as a whole $33 billion in 2007, according to a new report by the nonpartisan Congressional Budget Office. The CBO expected another $14 billion in annual savings to accrue as many new generics enter the market through 2012.
The main lobby for pharmacy benefit managers said the report also showed the advantages of pharmacy benefit managers.
“Tools pioneered by pharmacy benefit managers — including encouraging the use of generic medications — have lowered costs and expanded access to prescription drugs for seniors in Medicare Part D,” Pharmaceutical Care Management Association president and CEO Mark Merritt said.
The generic drug industry lobby hailed the report as well. “This new CBO study is just one of a continued body of evidence proving that generics are a key cost-saving component of our healthcare system,” a statement by the Generic Pharmaceutical Association read.
According to the market research firm IMS Health, generic drugs accounted for nearly 75% of prescriptions dispensed in the United States, but for just more than 19% of dollars spent.